Overview
A synthetic 39-amino-acid peptide engineered as a triple receptor agonist, designed to bind and activate the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR) simultaneously. This multi-receptor targeting strategy has made it a subject of laboratory research into combined incretin and glucagon receptor pharmacology.
| CAS number | 2381089-83-2 |
|---|---|
| Molecular weight | 4731.33 Da (C221H342N46O68) |
| Purity | >99.99% |
| Storage | -20C or colder |
| Appearance | White lyophilized powder |
| Contents | 10 mg |
| Lot | FF-RT10-260820-001 |